Trial Profile
Phase II randomized, double-blind, placebo-controlled study of TatImmune in ARV-treated HIV patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs HIV vaccine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 16 May 2016 New trial record